Incyte Corporation (INCY)
NASDAQ: INCY · Real-Time Price · USD
98.22
0.00 (0.00%)
At close: Jun 18, 2026, 4:00 PM EDT
99.94
+1.72 (1.75%)
Pre-market: Jun 22, 2026, 9:00 AM EDT

Incyte Revenue

Incyte had revenue of $1.27B in the quarter ending March 31, 2026, with 20.87% growth. This brings the company's revenue in the last twelve months to $5.36B, up 21.48% year-over-year. In the year 2025, Incyte had annual revenue of $5.14B with 21.22% growth.

Revenue (ttm)
$5.36B
Revenue Growth
+21.48%
P/S Ratio
3.66
Revenue / Employee
$1,885,028
Employees
2,844
Market Cap
19.62B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.14B900.02M21.22%
Dec 31, 20244.24B545.57M14.76%
Dec 31, 20233.70B301.01M8.87%
Dec 31, 20223.39B408.37M13.67%
Dec 31, 20212.99B319.57M11.98%
Dec 31, 20202.67B507.94M23.53%
Dec 31, 20192.16B276.88M14.71%
Dec 31, 20181.88B345.66M22.50%
Dec 31, 20171.54B430.50M38.93%
Dec 31, 20161.11B351.97M46.70%
Dec 31, 2015753.75M242.26M47.36%
Dec 31, 2014511.50M508.45M16,696.71%
Dec 31, 20133.05M-294.01M-98.97%
Dec 31, 2012297.06M202.60M214.50%
Dec 31, 201194.46M-75.42M-44.40%
Dec 31, 2010169.88M160.61M1,733.55%
Dec 31, 20099.27M5.35M136.41%
Dec 31, 20083.92M-30.52M-88.62%
Dec 31, 200734.44M6.80M24.59%
Dec 31, 200627.64M19.80M252.32%
Dec 31, 20057.85M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BeOne Medicines AG5.70B
Jazz Pharmaceuticals4.44B
Genmab3.90B
BioNTech SE3.23B
Exelixis2.38B
Moderna2.23B
Ascendis Pharma998.25M
Insmed819.56M
Revenue Rankings